Skip to main content

Table 3 Inter-rater agreement

From: Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool

 

Inter-rater agreement (%)

 

Overall

Part 1

Part 2

Part 3

1st pilot round (n = 5)

87.1

92.2

76.9

2nd pilot round (n = 4)

NA

NA

77.5

3rd round (n = 29)

NA

NA

86.4

  1. n, number of orphan medicinal products under review; NA, not applicable.